Sanfilippo syndrome, also known as Mucopolysaccharidosis Type III (MPS III), is a rare genetic disorder that affects the brain. It causes a progressive decline in mental and physical abilities, leading to a loss of cognitive and motor functions. Symptoms typically begin in children between the ages of 2 and 6 and result in total dependence as the disease progresses.
WHAT IS SANFILIPPO SYNDROME?
Sanfilippo syndrome is caused by a defect in the body’s ability to break down certain molecules known as glycosaminoglycans (GAGs). These molecules accumulate in cells, especially brain cells, because a specific enzyme required to degrade them is either missing or faulty. This buildup disrupts normal cell function, particularly in the brain, and leads to cellular damage.
There are four subtypes of this disease, each caused by a deficiency in a different enzyme:
- Type A: deficiency of the enzyme heparan N-sulfatase
- Type B: deficiency of the enzyme alpha-N-acetylglucosaminidase
- Type C: deficiency of the enzyme acetyl-CoA:alpha-glucosaminide N-acetyltransferase
- Type D: deficiency of the enzyme N-acetylglucosamine-6-sulfatase
These enzyme deficiencies lead to the accumulation of toxic substances, severely affecting the brain and other organs.
HOW IS SANFILIPPO SYNDROME INHERITED?
Sanfilippo syndrome is inherited in an autosomal recessive manner. This means that a child must inherit two copies of the faulty gene, one from each parent, to develop the disease.
Parents who each carry one defective gene copy are typically healthy but have a 25% chance with each pregnancy of having a child affected by the condition. This pattern of inheritance is common among rare diseases.
WHAT ARE THE SYMPTOMS?
Children with Sanfilippo syndrome appear healthy at birth, but symptoms usually start between the ages of 2 and 6. These may include:
- Developmental delays, particularly in speech
- Hyperactive behavior and difficulty concentrating
- Sleep disturbances
- Gradual loss of mental and physical abilities
- Seizures
- Trouble walking and moving normally
As the disease advances, children lose the ability to perform basic tasks such as eating or dressing independently. They become completely dependent on caregivers. The disease can also lead to frequent respiratory infections.
HOW IS the SAnfilippo syndrome DIAGNOSED?
Sanfilippo syndrome is diagnosed through several steps:
1- Urine analysis: shows elevated levels of GAGs, which may indicate the disease.
2- Enzyme tests: measure the activity of specific enzymes in the blood or cells to identify the subtype of MPS III.
3- Genetic testing: detects the mutations responsible for the condition.
Early diagnosis is essential to provide appropriate medical care and possibly enroll in clinical trials.
WHAT TREATMENT IS AVAILABLE for the syndrome?
Currently, there is no cure for Sanfilippo syndrome. Treatment focuses on managing symptoms and improving quality of life. This may include:
- Physical therapy to help maintain motor function for as long as possible
- Medication to control seizures
- Psychological support for families coping with the disease
- Palliative care in advanced stages to ensure comfort
Research is ongoing to develop more effective treatments, such as gene therapy to replace the faulty enzyme or substrate reduction therapies to limit the buildup of toxic substances.
WHAT IS THE LIFE EXPECTANCy?
Life expectancy depends on the disease subtype. On average:
- Type A: around 15 years
- Type B: around 19 years
- Type C: around 23 years
These averages may vary depending on how early the condition is diagnosed and the quality of care provided. While life expectancy is reduced, some treatments can improve the patient’s quality of life.
HOW CAN FAMILIES GET SUPPORT?
Several organizations provide support to families affected by Sanfilippo syndrome and help fund research into treatments:
Vaincre les Maladies Lysosomales (VML): supports families and finances research into better understanding and treating the disease.
Cure Sanfilippo Foundation: promotes research and raises awareness about the condition.
CONCLUSION
Sanfilippo syndrome is a rare and severe genetic disorder, but advances in research give families hope. While there is no cure yet, supportive care is available, and progress is being made every day.
Early diagnosis and proper care are crucial to improving the quality of life for affected children. Thanks to the dedication of researchers and advocacy groups, new solutions may emerge in the coming years.
Read:
